PDS5B_HUMAN - dbPTM
PDS5B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PDS5B_HUMAN
UniProt AC Q9NTI5
Protein Name Sister chromatid cohesion protein PDS5 homolog B
Gene Name PDS5B
Organism Homo sapiens (Human).
Sequence Length 1447
Subcellular Localization Nucleus .
Protein Description Regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. Plays a role in androgen-induced proliferative arrest in prostate cells..
Protein Sequence MAHSKTRTNDGKITYPPGVKEISDKISKEEMVRRLKMVVKTFMDMDQDSEEEKELYLNLALHLASDFFLKHPDKDVRLLVACCLADIFRIYAPEAPYTSPDKLKDIFMFITRQLKGLEDTKSPQFNRYFYLLENIAWVKSYNICFELEDSNEIFTQLYRTLFSVINNGHNQKVHMHMVDLMSSIICEGDTVSQELLDTVLVNLVPAHKNLNKQAYDLAKALLKRTAQAIEPYITNFFNQVLMLGKTSISDLSEHVFDLILELYNIDSHLLLSVLPQLEFKLKSNDNEERLQVVKLLAKMFGAKDSELASQNKPLWQCYLGRFNDIHVPIRLECVKFASHCLMNHPDLAKDLTEYLKVRSHDPEEAIRHDVIVSIVTAAKKDILLVNDHLLNFVRERTLDKRWRVRKEAMMGLAQIYKKYALQSAAGKDAAKQIAWIKDKLLHIYYQNSIDDRLLVERIFAQYMVPHNLETTERMKCLYYLYATLDLNAVKALNEMWKCQNLLRHQVKDLLDLIKQPKTDASVKAIFSKVMVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGCVREITKKLGNPKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSIDGTADDEDEGVPTDQAIRAGLELLKVLSFTHPISFHSAETFESLLACLKMDDEKVAEAALQIFKNTGSKIEEDFPHIRSALLPVLHHKSKKGPPRQAKYAIHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVTIGHIALLAPDQFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAIKMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLRLAAGSAIVKLAQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKGLSRLRLPLEYMAICALCAKDPVKERRAHARQCLVKNINVRREYLKQHAAVSEKLLSLLPEYVVPYTIHLLAHDPDYVKVQDIEQLKDVKECLWFVLEILMAKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVCDVAMNIIMSKSTTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTNVLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEMDHSENEDYTMSSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKLGMDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENEDEQNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEEEERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQSTPQKGRGRPSKTPSPSQPKKNVRVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRSAKRERR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
12AcetylationKTRTNDGKITYPPGV
CCCCCCCCCCCCCCC
34.447366845
20AcetylationITYPPGVKEISDKIS
CCCCCCCHHHHHHCC
56.077366855
20UbiquitinationITYPPGVKEISDKIS
CCCCCCCHHHHHHCC
56.0729967540
23PhosphorylationPPGVKEISDKISKEE
CCCCHHHHHHCCHHH
33.6622985185
25AcetylationGVKEISDKISKEEMV
CCHHHHHHCCHHHHH
41.9325953088
27PhosphorylationKEISDKISKEEMVRR
HHHHHHCCHHHHHHH
39.4922798277
28UbiquitinationEISDKISKEEMVRRL
HHHHHCCHHHHHHHH
62.2529967540
36UbiquitinationEEMVRRLKMVVKTFM
HHHHHHHHHHHHHHH
28.0423000965
40UbiquitinationRRLKMVVKTFMDMDQ
HHHHHHHHHHHCCCC
25.3223000965
41PhosphorylationRLKMVVKTFMDMDQD
HHHHHHHHHHCCCCC
16.7522067460
49PhosphorylationFMDMDQDSEEEKELY
HHCCCCCCHHHHHHH
41.07-
53AcetylationDQDSEEEKELYLNLA
CCCCHHHHHHHHHHH
57.1912650223
61 (in isoform 5)Ubiquitination-3.7121890473
80UbiquitinationDKDVRLLVACCLADI
CHHHHHHHHHHHHHH
4.5421890473
91PhosphorylationLADIFRIYAPEAPYT
HHHHHHHHCCCCCCC
16.31-
98PhosphorylationYAPEAPYTSPDKLKD
HCCCCCCCCHHHHHH
32.49-
102AcetylationAPYTSPDKLKDIFMF
CCCCCHHHHHHHHHH
61.9026822725
111PhosphorylationKDIFMFITRQLKGLE
HHHHHHHHHHHCCCC
10.91-
115UbiquitinationMFITRQLKGLEDTKS
HHHHHHHCCCCCCCC
53.7824816145
121UbiquitinationLKGLEDTKSPQFNRY
HCCCCCCCCCHHHHH
72.9022817900
121 (in isoform 1)Ubiquitination-72.9021890473
121 (in isoform 2)Ubiquitination-72.9021890473
121 (in isoform 3)Ubiquitination-72.9021890473
140O-linked_GlycosylationENIAWVKSYNICFEL
HHHHHHHHEEEEEEE
17.5031492838
212AcetylationPAHKNLNKQAYDLAK
HHCCCCCHHHHHHHH
39.207339641
215PhosphorylationKNLNKQAYDLAKALL
CCCCHHHHHHHHHHH
14.70-
219AcetylationKQAYDLAKALLKRTA
HHHHHHHHHHHHHHH
47.037339651
231UbiquitinationRTAQAIEPYITNFFN
HHHHHHHHHHHHHHH
21.5121890473
283PhosphorylationQLEFKLKSNDNEERL
HCEEEECCCCHHHHH
60.9125954137
294UbiquitinationEERLQVVKLLAKMFG
HHHHHHHHHHHHHHC
38.6429967540
298AcetylationQVVKLLAKMFGAKDS
HHHHHHHHHHCCCHH
34.4325953088
312AcetylationSELASQNKPLWQCYL
HHHHHCCCCCCEECC
33.5726051181
312UbiquitinationSELASQNKPLWQCYL
HHHHHCCCCCCEECC
33.5729967540
335AcetylationPIRLECVKFASHCLM
CEEHHHHHHHHHHHH
47.0425953088
338PhosphorylationLECVKFASHCLMNHP
HHHHHHHHHHHHHCH
20.1926126808
349UbiquitinationMNHPDLAKDLTEYLK
HHCHHHHHHHHHHHH
61.6429967540
354PhosphorylationLAKDLTEYLKVRSHD
HHHHHHHHHHHHCCC
13.44-
356AcetylationKDLTEYLKVRSHDPE
HHHHHHHHHHCCCHH
34.40-
356UbiquitinationKDLTEYLKVRSHDPE
HHHHHHHHHHCCCHH
34.4023000965
356 (in isoform 1)Ubiquitination-34.4021890473
356 (in isoform 2)Ubiquitination-34.4021890473
356 (in isoform 3)Ubiquitination-34.4021890473
380UbiquitinationSIVTAAKKDILLVND
HHHHHCCCCEEEECH
45.3229967540
417AcetylationMGLAQIYKKYALQSA
HHHHHHHHHHHHHHH
40.7219608861
4182-HydroxyisobutyrylationGLAQIYKKYALQSAA
HHHHHHHHHHHHHHC
20.84-
418UbiquitinationGLAQIYKKYALQSAA
HHHHHHHHHHHHHHC
20.8429967540
419PhosphorylationLAQIYKKYALQSAAG
HHHHHHHHHHHHHCC
14.37-
4272-HydroxyisobutyrylationALQSAAGKDAAKQIA
HHHHHCCHHHHHHHH
39.19-
427UbiquitinationALQSAAGKDAAKQIA
HHHHHCCHHHHHHHH
39.1929967540
499 (in isoform 3)Phosphorylation-39.6228450419
507UbiquitinationNLLRHQVKDLLDLIK
HHHHHHHHHHHHHHH
35.7721890473
507 (in isoform 1)Ubiquitination-35.7721890473
507 (in isoform 2)Ubiquitination-35.7721890473
514AcetylationKDLLDLIKQPKTDAS
HHHHHHHHCCCCCHH
68.7726051181
514UbiquitinationKDLLDLIKQPKTDAS
HHHHHHHHCCCCCHH
68.7729967540
518O-linked_GlycosylationDLIKQPKTDASVKAI
HHHHCCCCCHHHHHH
43.4031492838
518PhosphorylationDLIKQPKTDASVKAI
HHHHCCCCCHHHHHH
43.4021712546
5232-HydroxyisobutyrylationPKTDASVKAIFSKVM
CCCCHHHHHHHHHEE
33.01-
527PhosphorylationASVKAIFSKVMVITR
HHHHHHHHHEEEEEC
20.4424719451
528AcetylationSVKAIFSKVMVITRN
HHHHHHHHEEEEECC
24.4926051181
533PhosphorylationFSKVMVITRNLPDPG
HHHEEEEECCCCCCC
11.3321712546
5482-HydroxyisobutyrylationKAQDFMKKFTQVLED
HHHHHHHHHHHHHCC
41.68-
548AcetylationKAQDFMKKFTQVLED
HHHHHHHHHHHHHCC
41.6825953088
558AcetylationQVLEDDEKIRKQLEV
HHHCCHHHHHHHHHH
55.6025953088
558UbiquitinationQVLEDDEKIRKQLEV
HHHCCHHHHHHHHHH
55.6033845483
572PhosphorylationVLVSPTCSCKQAEGC
HHCCCCCCCHHCCHH
27.1620068231
574UbiquitinationVSPTCSCKQAEGCVR
CCCCCCCHHCCHHHH
35.93-
627UbiquitinationALIKQVNKSIDGTAD
HHHHHHHHHCCCCCC
50.3529967540
628PhosphorylationLIKQVNKSIDGTADD
HHHHHHHHCCCCCCC
22.25-
693UbiquitinationEAALQIFKNTGSKIE
HHHHHHHHHCCCCCH
56.0529967540
698AcetylationIFKNTGSKIEEDFPH
HHHHCCCCCHHHCHH
56.3226051181
698UbiquitinationIFKNTGSKIEEDFPH
HHHHCCCCCHHHCHH
56.3229967540
717UbiquitinationLLPVLHHKSKKGPPR
HHHHHCCCCCCCCHH
53.9029967540
728PhosphorylationGPPRQAKYAIHCIHA
CCHHHHHHHHHHHHH
17.50-
787PhosphorylationQFAAPLKSLVATFIV
HHHHHHHHHHHHHHH
35.44-
795AcetylationLVATFIVKDLLMNDR
HHHHHHHHHHHHCCC
37.5326051181
802MethylationKDLLMNDRLPGKKTT
HHHHHCCCCCCCCCC
37.47-
810AcetylationLPGKKTTKLWVPDEE
CCCCCCCEEECCCCC
45.6525953088
810UbiquitinationLPGKKTTKLWVPDEE
CCCCCCCEEECCCCC
45.6529967540
813UbiquitinationKKTTKLWVPDEEVSP
CCCCEEECCCCCCCH
6.5823000965
827UbiquitinationPETMVKIQAIKMMVR
HHHHHHHHHHHHHHH
31.1721890473
844PhosphorylationLGMKNNHSKSGTSTL
HCCCCCCCCCCHHHH
30.55-
872UbiquitinationTEQGKISKPDMSRLR
CCCCCCCCCCHHHHH
48.8129967540
964AcetylationHARQCLVKNINVRRE
HHHHHHHHHHHHCHH
38.8825953088
974UbiquitinationNVRREYLKQHAAVSE
HHCHHHHHHHHHHHH
38.8529967540
985PhosphorylationAVSEKLLSLLPEYVV
HHHHHHHHHCHHHHH
37.99-
990PhosphorylationLLSLLPEYVVPYTIH
HHHHCHHHHHHHHHH
12.57-
1005PhosphorylationLLAHDPDYVKVQDIE
HHHCCCCCCCCCCHH
13.93-
1015UbiquitinationVQDIEQLKDVKECLW
CCCHHHHCCHHHHHH
61.2329967540
1050PhosphorylationMVENIKQTKDAQGPD
HHHHHHHCCCCCCCC
26.3719651622
1060AcetylationAQGPDDAKMNEKLYT
CCCCCCHHHHHHHHH
49.6126051181
1066PhosphorylationAKMNEKLYTVCDVAM
HHHHHHHHHHHHHHH
14.2723403867
1067PhosphorylationKMNEKLYTVCDVAMN
HHHHHHHHHHHHHHH
25.7023403867
1078PhosphorylationVAMNIIMSKSTTYSL
HHHHHHHCCCCCCCC
17.0424275748
1080PhosphorylationMNIIMSKSTTYSLES
HHHHHCCCCCCCCCC
20.7623403867
1081PhosphorylationNIIMSKSTTYSLESP
HHHHCCCCCCCCCCC
33.2323403867
1082PhosphorylationIIMSKSTTYSLESPK
HHHCCCCCCCCCCCC
20.4323403867
1083PhosphorylationIMSKSTTYSLESPKD
HHCCCCCCCCCCCCC
16.0224144214
1084PhosphorylationMSKSTTYSLESPKDP
HCCCCCCCCCCCCCC
24.4623403867
1087PhosphorylationSTTYSLESPKDPVLP
CCCCCCCCCCCCCCC
42.4125159151
1089AcetylationTYSLESPKDPVLPAR
CCCCCCCCCCCCCCH
81.5626051181
1089UbiquitinationTYSLESPKDPVLPAR
CCCCCCCCCCCCCCH
81.5623000965
1103AcetylationRFFTQPDKNFSNTKN
HHCCCCCCCCCCCCC
67.5888031
1103UbiquitinationRFFTQPDKNFSNTKN
HHCCCCCCCCCCCCC
67.5821890473
1103 (in isoform 1)Ubiquitination-67.5821890473
1103 (in isoform 2)Ubiquitination-67.5821890473
1109UbiquitinationDKNFSNTKNYLPPEM
CCCCCCCCCCCCHHH
48.0929967540
1118PhosphorylationYLPPEMKSFFTPGKP
CCCHHHHHCCCCCCC
25.0430266825
1121PhosphorylationPEMKSFFTPGKPKTT
HHHHHCCCCCCCCCC
29.1730266825
1124AcetylationKSFFTPGKPKTTNVL
HHCCCCCCCCCCCHH
44.5425953088
1127PhosphorylationFTPGKPKTTNVLGAV
CCCCCCCCCCHHHHH
31.9329396449
1128PhosphorylationTPGKPKTTNVLGAVN
CCCCCCCCCHHHHHC
29.4729396449
1136AcetylationNVLGAVNKPLSSAGK
CHHHHHCCCCHHCCC
40.5119608861
1139PhosphorylationGAVNKPLSSAGKQSQ
HHHCCCCHHCCCCCC
27.0322167270
1140PhosphorylationAVNKPLSSAGKQSQT
HHCCCCHHCCCCCCC
49.0422167270
1143AcetylationKPLSSAGKQSQTKSS
CCCHHCCCCCCCCCC
46.6326051181
1145PhosphorylationLSSAGKQSQTKSSRM
CHHCCCCCCCCCCCC
43.2129214152
1147PhosphorylationSAGKQSQTKSSRMET
HCCCCCCCCCCCCHH
37.8321712546
1149PhosphorylationGKQSQTKSSRMETVS
CCCCCCCCCCCHHHH
26.9426074081
1150PhosphorylationKQSQTKSSRMETVSN
CCCCCCCCCCHHHHC
36.8826074081
1154PhosphorylationTKSSRMETVSNASSS
CCCCCCHHHHCCCCC
21.6423927012
1156PhosphorylationSSRMETVSNASSSSN
CCCCHHHHCCCCCCC
33.8123927012
1159PhosphorylationMETVSNASSSSNPSS
CHHHHCCCCCCCCCC
34.7023927012
1160PhosphorylationETVSNASSSSNPSSP
HHHHCCCCCCCCCCC
35.0623927012
1160 (in isoform 2)Phosphorylation-35.0621406692
1161PhosphorylationTVSNASSSSNPSSPG
HHHCCCCCCCCCCCC
31.4729255136
1161 (in isoform 2)Phosphorylation-31.4721406692
1162PhosphorylationVSNASSSSNPSSPGR
HHCCCCCCCCCCCCC
55.5029255136
1165PhosphorylationASSSSNPSSPGRIKG
CCCCCCCCCCCCCCC
54.1129255136
1165 (in isoform 2)Phosphorylation-54.1121406692
1166PhosphorylationSSSSNPSSPGRIKGR
CCCCCCCCCCCCCCC
32.4119664994
1166 (in isoform 2)Phosphorylation-32.4121406692
1176PhosphorylationRIKGRLDSSEMDHSE
CCCCCCCCCCCCCCC
32.5622167270
1176 (in isoform 2)Phosphorylation-32.5621406692
1177PhosphorylationIKGRLDSSEMDHSEN
CCCCCCCCCCCCCCC
36.2922167270
1177 (in isoform 2)Phosphorylation-36.2921406692
1182PhosphorylationDSSEMDHSENEDYTM
CCCCCCCCCCCCCCC
37.5422167270
1182 (in isoform 2)Phosphorylation-37.5421406692
1187PhosphorylationDHSENEDYTMSSPLP
CCCCCCCCCCCCCCC
9.7322167270
1188PhosphorylationHSENEDYTMSSPLPG
CCCCCCCCCCCCCCC
23.9323927012
1188 (in isoform 2)Phosphorylation-23.9321406692
1190PhosphorylationENEDYTMSSPLPGKK
CCCCCCCCCCCCCCC
22.4723401153
1190 (in isoform 2)Phosphorylation-22.4721406692
1191PhosphorylationNEDYTMSSPLPGKKS
CCCCCCCCCCCCCCC
21.4523927012
1191 (in isoform 2)Phosphorylation-21.4521406692
1196AcetylationMSSPLPGKKSDKRDD
CCCCCCCCCCCCCCC
47.3525953088
1198PhosphorylationSPLPGKKSDKRDDSD
CCCCCCCCCCCCCHH
52.4222210691
1204PhosphorylationKSDKRDDSDLVRSEL
CCCCCCCHHHHHHHH
36.8125849741
1209PhosphorylationDDSDLVRSELEKPRG
CCHHHHHHHHCCCCC
38.7725159151
1213AcetylationLVRSELEKPRGRKKT
HHHHHHCCCCCCCCC
53.2783035809
1220PhosphorylationKPRGRKKTPVTEQEE
CCCCCCCCCCCHHHH
26.4825159151
1223PhosphorylationGRKKTPVTEQEEKLG
CCCCCCCCHHHHHHC
32.9023403867
1228AcetylationPVTEQEEKLGMDDLT
CCCHHHHHHCHHHHH
49.9812656425
1231SulfoxidationEQEEKLGMDDLTKLV
HHHHHHCHHHHHHHH
5.4021406390
1235PhosphorylationKLGMDDLTKLVQEQK
HHCHHHHHHHHHHHC
29.3519664994
1242AcetylationTKLVQEQKPKGSQRS
HHHHHHHCCCCCCCC
48.2025953088
1246PhosphorylationQEQKPKGSQRSRKRG
HHHCCCCCCCCHHCC
28.6623401153
1249PhosphorylationKPKGSQRSRKRGHTA
CCCCCCCCHHCCCCC
34.2227174698
1255PhosphorylationRSRKRGHTASESDEQ
CCHHCCCCCCCCHHH
34.4022167270
1255 (in isoform 2)Phosphorylation-34.4021406692
1257PhosphorylationRKRGHTASESDEQQW
HHCCCCCCCCHHHCC
38.5022167270
1257 (in isoform 2)Phosphorylation-38.5021406692
1259PhosphorylationRGHTASESDEQQWPE
CCCCCCCCHHHCCCH
43.9122167270
1259 (in isoform 2)Phosphorylation-43.9121406692
1283PhosphorylationENEDEQNSPPKKGKR
HCCCCCCCCCCCCCC
42.1219664994
1283 (in isoform 2)Phosphorylation-42.1221406692
1301PhosphorylationPKPLGGGTPKEEPTM
CCCCCCCCCCCCCCC
34.1725159151
1307PhosphorylationGTPKEEPTMKTSKKG
CCCCCCCCCCCCCCC
34.2827251275
1309AcetylationPKEEPTMKTSKKGSK
CCCCCCCCCCCCCCC
52.7225953088
1319PhosphorylationKKGSKKKSGPPAPEE
CCCCCCCCCCCCCHH
66.4723401153
1334PhosphorylationEEEEERQSGNTEQKS
HHHHHHHCCCCCHHH
39.9923401153
1337PhosphorylationEERQSGNTEQKSKSK
HHHHCCCCCHHHHHH
43.2326657352
1341PhosphorylationSGNTEQKSKSKQHRV
CCCCCHHHHHHHHHH
41.6826657352
1343PhosphorylationNTEQKSKSKQHRVSR
CCCHHHHHHHHHHHH
44.6426657352
1344MethylationTEQKSKSKQHRVSRR
CCHHHHHHHHHHHHH
54.59-
1349PhosphorylationKSKQHRVSRRAQQRA
HHHHHHHHHHHHHHH
18.92-
1358PhosphorylationRAQQRAESPESSAIE
HHHHHHHCCCCHHHH
32.7419664994
1358 (in isoform 2)Phosphorylation-32.7421406692
1361PhosphorylationQRAESPESSAIESTQ
HHHHCCCCHHHHCCC
28.5829255136
1361 (in isoform 2)Phosphorylation-28.5821406692
1362PhosphorylationRAESPESSAIESTQS
HHHCCCCHHHHCCCC
31.4429255136
1366PhosphorylationPESSAIESTQSTPQK
CCCHHHHCCCCCCCC
26.1529255136
1366 (in isoform 2)Phosphorylation-26.1521406692
1367PhosphorylationESSAIESTQSTPQKG
CCHHHHCCCCCCCCC
17.4729255136
1369PhosphorylationSAIESTQSTPQKGRG
HHHHCCCCCCCCCCC
41.9929255136
1370PhosphorylationAIESTQSTPQKGRGR
HHHCCCCCCCCCCCC
21.6629255136
1379PhosphorylationQKGRGRPSKTPSPSQ
CCCCCCCCCCCCCCC
48.0422167270
1379 (in isoform 2)Phosphorylation-48.0425849741
1380AcetylationKGRGRPSKTPSPSQP
CCCCCCCCCCCCCCC
68.1125953088
1381PhosphorylationGRGRPSKTPSPSQPK
CCCCCCCCCCCCCCC
33.0822167270
1381 (in isoform 2)Phosphorylation-33.0825849741
1383PhosphorylationGRPSKTPSPSQPKKN
CCCCCCCCCCCCCCC
42.2722167270
1383 (in isoform 2)Phosphorylation-42.2725849741
1385PhosphorylationPSKTPSPSQPKKNVR
CCCCCCCCCCCCCCC
64.5530266825
1385 (in isoform 2)Phosphorylation-64.5525849741
1396PhosphorylationKNVRVGRSKQAATKE
CCCCCCCCCCCCCCC
24.1630624053
1401PhosphorylationGRSKQAATKENDSSE
CCCCCCCCCCCCCCC
41.7425921289
1406PhosphorylationAATKENDSSEEVDVF
CCCCCCCCCCCCCCC
51.7530266825
1407PhosphorylationATKENDSSEEVDVFQ
CCCCCCCCCCCCCCC
40.4130266825
1416PhosphorylationEVDVFQGSSPVDDIP
CCCCCCCCCCCCCCC
22.2328102081
1417PhosphorylationVDVFQGSSPVDDIPQ
CCCCCCCCCCCCCCH
35.4528102081
1427PhosphorylationDDIPQEETEEEEVST
CCCCHHHCCCHHHHH
48.2028464451
1433PhosphorylationETEEEEVSTVNVRRR
HCCCHHHHHHHHHHH
29.8927251275
1434PhosphorylationTEEEEVSTVNVRRRS
CCCHHHHHHHHHHHH
22.6727251275
1441PhosphorylationTVNVRRRSAKRERR-
HHHHHHHHHHHHCC-
36.0126074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
1370TPhosphorylationKinaseCDK1P06493
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PDS5B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PDS5B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMC1A_HUMANSMC1Aphysical
17113138
STAG1_HUMANSTAG1physical
17113138
STAG2_HUMANSTAG2physical
17113138
SMC3_HUMANSMC3physical
17113138
RAD21_HUMANRAD21physical
17112726
WFDC5_HUMANWFDC5physical
17112726
SMC1A_HUMANSMC1Aphysical
15855230
SMC3_HUMANSMC3physical
15855230
RAD21_HUMANRAD21physical
15855230
STAG1_HUMANSTAG1physical
15855230
STAG2_HUMANSTAG2physical
15855230
A4_HUMANAPPphysical
21832049
BRCA2_HUMANBRCA2physical
22293751
RAD51_HUMANRAD51physical
22293751
PALB2_HUMANPALB2physical
22293751
CDC45_HUMANCDC45physical
22293751
PCNA_HUMANPCNAphysical
22293751
RAD21_HUMANRAD21physical
22293751
SMC3_HUMANSMC3physical
22293751
PDS5A_HUMANPDS5Aphysical
26344197
SMC3_HUMANSMC3physical
26344197
STAG1_HUMANSTAG1physical
26344197
WAPL_HUMANWAPALphysical
17113138

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PDS5B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1136, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1162; SER-1166;SER-1176; SER-1182; SER-1191; SER-1257; SER-1283; SER-1358 ANDTHR-1370, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1162; SER-1165;SER-1166; SER-1358; SER-1361 AND THR-1370, AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1358 AND THR-1367, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1358 AND THR-1370, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1257 AND SER-1383, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1257; SER-1283; SER-1319AND SER-1334, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1166; SER-1182;SER-1283; THR-1301; SER-1358 AND THR-1370, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1358, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1166 AND SER-1358, ANDMASS SPECTROMETRY.
"Complete sequencing and characterization of 21,243 full-length humancDNAs.";
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
Nat. Genet. 36:40-45(2004).
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).

TOP